Genus (FRA:GBE) Other Stockholders Equity : €22.8 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Genus Other Stockholders Equity?

Genus's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €22.8 Mil.

Genus's quarterly Other Stockholders Equity declined from Dec. 2022 (€49.2 Mil) to Jun. 2023 (€27.0 Mil) and declined from Jun. 2023 (€27.0 Mil) to Dec. 2023 (€22.8 Mil).

Genus's annual Other Stockholders Equity increased from Jun. 2021 (€-15.1 Mil) to Jun. 2022 (€54.3 Mil) but then declined from Jun. 2022 (€54.3 Mil) to Jun. 2023 (€27.0 Mil).

Genus Other Stockholders Equity Historical Data

The historical data trend for Genus's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Other Stockholders Equity Chart

Genus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Stockholders Equity

Get a 7-Day Free Trial

34.21

26.34

-15.13

54.29

27.04

Genus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															-11.06	54.29	49.21	27.04	22.75

Genus Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Genus Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genus's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (FRA:GBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (FRA:GBE) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

GENSF:USA GNSl:UK GNS:UK

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus (FRA:GBE) Headlines

No Headlines